2025 · 2nd Quarter (Apr 1 - June 30)

TAKEDA PHARMACEUTICAL COMPANY

Filed by MR. BRIAN KELLY.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 19, 2025
Income: $10,000.00
Expenses: Not reported
Registrant: MR. BRIAN KELLY
Client: TAKEDA PHARMACEUTICAL COMPANY
Filing UUID: e0192b35-dcd9-467e-80a6-53145e3bad8a
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Trade and tariffs

TAR · Tariff (miscellaneous tariff bills)

Government tariffs on drug imporatation.

TRD · Trade (domestic/foreign)

Trade/Tariffs on drug pricing and importation

TAX · Taxation/Internal Revenue Code

tax issues related to drugs and pricing

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.